0000000000-25-002308.txt : 20250416 0000000000-25-002308.hdr.sgml : 20250416 20250228153607 ACCESSION NUMBER: 0000000000-25-002308 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250228 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: Nurix Therapeutics, Inc. CENTRAL INDEX KEY: 0001549595 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 270838048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: UPLOAD SEC FILE NUMBER: 001-39398 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (415) 660-5320 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: Nurix, Inc. DATE OF NAME CHANGE: 20120509 PUBLIC REFERENCE ACCESSION NUMBER: 0001549595-25-000016 LETTER 1 filename1.pdf begin 644 filename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end TEXT-EXTRACT 2 filename2.txt February 28, 2025 Hans van Houte Chief Financial Officer Nurix Therapeutics, Inc. 1700 Owens Street, Suite 205 San Francisco, CA 94158 Re: Nurix Therapeutics, Inc. Form 10-K for Fiscal Year Ended November 30, 2024 File No. 001-39398 Dear Hans van Houte: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K for Fiscal Year Ended November 30, 2024 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations Research and Development Expenses , page 121 1. You disclose on page 117 that you track external research and development costs for each of your drug candidates. Please provide revised disclosure to be included in future filings that breaks out your research and development costs for each of your drug candidates. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. February 28, 2025 Page 2 Please contact Eric Atallah at 202-551-3663 or Kevin Kuhar at 202-551-3662 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences